SCHEMBL5744686

SCHEMBL5744686

OC1CN(C(c2ccccc2)(c2ccccc2)c2ccccc2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.37
CYP2B6 P20813 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
ATM Q13315 1/20 0.35
KCNA3 P22001 2/20 0.35
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
FUCA1 P04066 2/20 0.33
ALDH1A1 P00352 2/20 0.33
CHRM3 P20309 2/20 0.33
MEN1 O00255 1/20 0.33
CYP2D6 P10635 1/20 0.33
HRH1 P35367 1/20 0.33
SCN1A P35498 1/20 0.33
KMT2A Q03164 1/20 0.33
SCN2A Q99250 1/20 0.33
SCN3A Q9NY46 1/20 0.33
KEAP1 Q14145 1/20 0.32
NFE2L2 Q16236 1/20 0.32
TSHR P16473 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5743640 0.88 CYP2D6 (0.41) LMNAL3MBTL1ATMALDH1A1CHRM3
SCHEMBL1528518 0.84 KCNA3 (0.41) LMNACYP2B6L3MBTL1ATMKCNA3
SCHEMBL2493505 0.84 KCNA3 (0.41) LMNACYP2B6L3MBTL1ATMKCNA3
SCHEMBL4391647 0.81 ALDH1A1 (0.49) LMNACYP2B6L3MBTL1ATMALDH1A1
SCHEMBL5743595 0.79 KCNA3 (0.46) LMNACYP2B6L3MBTL1ATMKCNA3
SCHEMBL3346414 0.79 LMNA (0.35) LMNACYP2B6L3MBTL1ATMKCNA3
SCHEMBL5746287 0.79 SMN1; SMN2 (0.42) LMNAL3MBTL1ALDH1A1MEN1CYP2D6
SCHEMBL5744205 0.79 MAPT (0.41) LMNACYP2B6L3MBTL1ATMFUCA1
Hydrochloric Acid SCHEMBL11044496 0.78 LMNA (0.38) LMNACYP2B6L3MBTL1ATMKCNA3
Ethane SCHEMBL27569967 0.76 KCNA3 (0.44) LMNACYP2B6L3MBTL1ATMKCNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111825592-B Synthetic method of 3-hydroxyazetidine hydrochloride 四川同晟生物医药有限公司 2022-07-29 CN claimed
CN-111825592-A Synthetic method of 3-hydroxyazetidine hydrochloride 四川同晟生物医药有限公司 2020-10-27 CN claimed
CN-111825592-B Synthetic method of 3-hydroxyazetidine hydrochloride 四川同晟生物医药有限公司 2022-07-29 CN disclosed
CN-111825592-B Synthetic method of 3-hydroxyazetidine hydrochloride 四川同晟生物医药有限公司 2022-07-29 CN disclosed
CN-111825592-A Synthetic method of 3-hydroxyazetidine hydrochloride 四川同晟生物医药有限公司 2020-10-27 CN disclosed
CN-111825592-A Synthetic method of 3-hydroxyazetidine hydrochloride 四川同晟生物医药有限公司 2020-10-27 CN disclosed
EP-1288198-B1 PROCESS FOR THE PRODUCTION OF SULFONIC ESTERS KANEKA CORP (JP) 2006-12-20 EP disclosed
US-6992205-B2 Process for the production of sulfonic esters KANEKA CORPORATION (JP) 2006-01-31 US disclosed
US-6864372-B2 Process for the production of sulfonic esters KANEKA CORPORATION (JP) 2005-03-08 US disclosed
US-6794519-B2 Process for the production of sulfonic esters KANEKA CORPORATION (JP) 2004-09-21 US disclosed
US-20030176711-A1 Process for the production of sulfonic esters KANEKA CORPORATION (JP) 2003-09-18 US disclosed
US-20030176713-A1 Reacting an amino alcohol derivative with organic sulfonyl halide in a mixed solvent composed of an aprotic organic solvent and water in presence of a non-water prohibiting inorganic base KANEKA CORPORATION (JP) 2003-09-18 US disclosed
US-20030162966-A1 PROCESS FOR THE PRODUCTION OF SULFONIC ESTERS KANEKA CORPORATION (JP) 2003-08-28 US disclosed
EP-1288198-A1 PROCESS FOR THE PRODUCTION OF SULFONIC ESTERS KANEKA CORPORATION (JP) 2003-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162966-A1 PROCESS FOR THE PRODUCTION OF SULFONIC ESTERS TST, STS, SELENOI LMNA 3382/4885CYP2B6 186/4885L3MBTL1 3101/4885
US-20030176711-A1 Process for the production of sulfonic esters TST, STS, SELENOI LMNA 3382/4885CYP2B6 186/4885L3MBTL1 3101/4885
US-20030176713-A1 Reacting an amino alcohol derivative with organic sulfonyl halide in a mixed solvent composed of an aprotic organic solvent and water in presence of a non-water prohibiting inorganic base BRAF, ADH1C, TST LMNA 2764/4885CYP2B6 756/4885L3MBTL1 2186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.